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ABSTRACT
The treatment of cancer with chemotherapeutic agents has made great strides in
the last few decades but still introduces major systemic side effects. The potent drugs
needed to kill cancer cells often cause irreparable damage to otherwise healthy organs
leading to further morbidity and mortality. A therapy with intrinsic selective properties
and/or an inducible activation has the potential to change the way cancer can be treated.
Gold nanoparticles (GNPs) are biocompatible and chemically versatile tools that can be
readily functionalized to serve as molecular vehicles. The ability of these particles to
strongly absorb light with wavelengths in the therapeutic window combined with the
heating effect of surface plasmon resonance makes them uniquely suited for noninvasive
heating in biologic applications. Specially designed DNA aptamers have shown their
ability to serve as drug carriers through intercalation as well as directly acting as
therapeutic agents. By combining these separate molecules a multifaceted drug delivery
vehicle can be created with great potential as a selective and controllable treatment for
cancer.
Oligonucleotide-coated GNPs have been created using spherical GNPs but little
work has been reported using gold nanoplates in this way. Using the Diasynth method
gold nanoplates were produced to absorb strongly in the therapeutic near infrared (nIR)
window. These particles were functionalized with two DNA oligonucleotides: one
serving as an intercalation site for doxorubicin, and another, AS1411, serving directly as
an anticancer targeting/therapeutic agent. These functional particles were fully
synthesized and processed along with confirmation of DNA functionalization and
doxorubicin intercalation. Doxorubicin is released via denaturation of the DNA structure
into which doxorubicin is intercalated upon the heating of the gold nanoplate well above
iv

the DNA melting temperature. This temperature increase, due to light stimulation of
surface plasmon resonance, was measured during laser application. Successful release of
doxorubicin via laser application was measured with fluorescence measurements
providing proof that the doxorubicin was successfully intercalated and released.
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I. INTRODUCTION

A. Problem Statement
Gold nanoparticles (GNPs) have been studied for many years, due to their unique
optical and physical characteristics, with the vast majority of research being done with gold
nanospheres, the most common and easily produced particle type. More recently research
has been done on more complex geometries of GNPs, such as nanoplates, which exhibit
similar overall characteristics as gold nanospheres but with some outstanding features, such
as high absorbance in the near-infrared (nIR) region of the electromagnetic spectrum. Due
to high transmissivity of nIR light through biological media, this feature has proved
invaluable for targeted photothermal ablation of living tissue with minimal collateral
damage when targeting cancer cells (Gobin 2010). With the ability to reproducibly
synthesize a large batch of gold nanoplates, using a technique such as Diasynth (Patel
2012), the unique therapeutic possibilities of these particles can be explored.
Conjugation of GNPs with various macromolecules has been studied for the ability
to provide stability as well as drug delivery options to create versatile platforms for
biological applications (Delong 2010). One such biomolecule that has become popular for
this application in recent years is oligonucleotides. The application of DNA/RNA strands
to create tertiary structures such as stem loops, or hairpins, has also been used
independently to create biologically compatible drug delivery platforms through
intercalation of therapeutic agents (Agudelo 2014). These drugs can then be released
through thermal, chemical, or enzymatic denaturation of the DNA. Still other sequences of
single stranded DNA, such as the guanosine-rich aptamer AS1411, have been found to
1

have direct therapeutic effects against cancer cells (Stahel 2003, Bates 2009). The method
of action of AS1411 is through geometric recognition with cell surface proteins only
present on cancer cells, making AS1411 effectively inert to noncancerous cells. The
clinical potential of AS1411 has been curtailed through short systemic circulation time.
By conjugating a hairpin structure to the surface of a gold nanoparticle, thermal
denaturation can be achieved by heating the gold through application of external light to
induce localized surface plasmon resonance (Gobin 2010). DNA-functionalization of
GNPs, intercalation of dox into hairpin DNA, and creation of therapeutic DNA aptamers
alone have been accomplished. Research has been broad with applications ranging from
creating higher order supramolecular structures, selective binding of aptamers to cells or
other DNA, or use as diagnostic marker for biosensing (Song 2010, Delong 2010). Each
has shown some success as a tool for cancer therapy but not without limitations. A single
complex combining all of these types of therapeutic modalities has the potential to bring a
multifaceted approach to cancer therapy. This would include the selective molecular effects
of the AS1411, the induced drug release of the hairpin, and the thermal effect of the GNPs.
B. Background
Cancer has been one of the largest causes of mortality globally and the number of
cancer cases is continually rising (Bode 2009). Standard treatments for cancer consist of
either radiation, chemotherapy, or both, which can have devastating side effects (Chabner
2005). One of the largest drawbacks of chemotherapy is the lack of specificity and
controllability in the effect of the drug, often leading to dose-limited application that risks
severe damage to otherwise healthy organs. It is desirable to have a treatment that could be
deployed such that the active drug would remain sequestered until released via a controlled
2

secondary mechanism, or a drug that exhibits specificity in only damaging the cancerous
tissue.
GNPs have been used for decades in biological applications for the detection,
diagnosis, and treatment of various diseases, utilizing the unique chemical and optical
properties of nano-sized gold. They can also cover a broad spectrum of sizes, geometries
(including spheres, rods, and plates), and compositions, each of which has unique
characteristics. For biological applications GNPs are useful for their small size,
biocompatibility, and ability to be conjugated easily with other molecules (Delong 2010).
Sizes of GNPs can range from one nanometer to over 120 nanometers (Boisselier 2009),
but for therapeutic applications size is most immediately relevant to the ability of the
particles to reach the desired region in the body. In the case of intravenous cancer treatment
the minimum size would be directly dependent on the perforations of the endothelium
providing tumor perfusion (Iyer 2006), which have been shown to be larger in tumor
vasculature than healthy vessels, a phenomenon referred to as the enhanced permeability
and retention effect, or EPR.
The major determining factor for particle geometry is the chemical synthesis and
resulting composition of the GNPs. Through the reaction of a gold salt, tetrachloroauric
acid, with sodium thiosulfate in a cellulose acetate dialysis membrane non-spherical gold
particles can be created in a one-step reaction without the use of seeds or other capping
agents. Furthermore, using the “Diasynth” method gold nanoplates can be synthesized to
be tuned to a desired size, directly corresponding to a maximum absorbance wavelength in
the near-infrared range, by controlling the surface area of cellulose membrane and reaction
temperature (James 2013, Patel 2012). Gold nanoplates are the main product of this
3

reaction although smaller spherical GNPs are also formed, and can be removed through
physical separation (Zhang 2012). Generally gold nanoplate dimensions measure from 40
nm to 1 um edge length and 5 to 50 nm thick with the possibility of truncation of the
vertices. Synthesis in solution usually produces single crystalline face-centered cubic
lattices. Edge length, thickness, and truncation all ultimately affect the light extinction
properties, and are to some degree controllable (Millstone 2009).
The most important property of GNPs for cancer therapy is a phenomenon known
as localized surface plasmon resonance, or LSPR. Localized surface plasmon resonance is
a well-studied ability of colloidal metal particles to vibrate at high frequency when exposed
to an electromagnetic field. This is caused by the creation of an electric dipole within the
particle, due to a difference in electron density, causing the particle to oscillate in turn with
the frequency of the electric field of the incoming light. The application of this effect is
even further magnified in potential when it is coupled with the near-infrared transparency
of human skin. The wavelength range from 650 to 950 nm is known as the optical, or
therapeutic, window for biomedical applications due to the dip in absorbance seen for many
biologic media as seen in FIGURE 1. The bounds of this window consist of oxygenated
and deoxygenated hemoglobin increasing in absorbance at the visible end of the window
and water increasing at the infrared end. This indicates not only will minimal absorbance
be seen in this window but maximum transmission as well. Utilizing the LSPR effect within
the range of the therapeutic window allows for optimal excitation of GNPs with minimal
damage to other tissue. Studies have shown the use of GNPs in this way for the treatment
of tumors in mice (Gobin 2010 and Hirsch 2003).

4

FIGURE 1 The near-infrared window from 650-900 nm with minimal absorbance of
biologic materials (Weissleder, 2001)

To enhance the abilities of GNPs various studies have looked at the potential of
forming functional layers on the exterior of the gold surface. Conjugation of GNPs with a
variety of molecules has been researched. The high affinity binding of sulfhydryl, or thiol,
groups for gold surfaces, has been heavily exploited to allow for coating with thiolated
molecules such as polyethylene glycol, DNA, or RNA (Ghosh 2008). Through
functionalization with these molecules the particles can become more resistant to
aggregation, self-assemble to form larger structures such as lattices, or serve as vectors for
gene or drug delivery (Witten 2008, Delong 2010). Characterization of DNAfunctionalized spherical GNPs has been reported rather extensively utilizing techniques
including SEM imaging, optical spectroscopy, dynamic light scattering, and
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electrophoresis. Additionally, drug release from coated spherical GNPs has been studied
both with and without in vitro cell studies analyzing cytotoxicity. However, most of this
research has been done using spherical GNPs (Delong 2010). The use of gold nanoplates
in this manner has much fewer reports but the approach in principle is identical.
DNA aptamers are functional structures composed of nucleotides or peptides to
bind to specific molecules or enzymes. They are similar in action to antibodies, which can
inhibit signal pathways or signal for immune response to cancer cells, using a key-and-lock
type site of recognition. Aptamers, being composed of nucleotides or peptides, can still
bind to surface receptors but can also disrupt transcription and translation processes. One
molecule that has already shown great promise as a standalone cancer treatment is the DNA
aptamer AS1411 (Bates 2009). The sequence, discovered and developed by Bates et al.,
consisting of a guanosine-rich oligonucleotide chain that has been shown to form
quadruplex structures known as G-quartets, as seen in FIGURE 2, which can have protein
binding properties. Physiologically these structures have shown several unique
characteristics that give them great potential as a chemotherapeutic agent. While AS1411
exhibits decreased vulnerability to nuclease activity, increased uptake by cancer cells, and
anti-proliferative effects the mechanisms of action for the molecule has been and continues
to be studied. The current understanding of the mechanism concludes that nucleolin protein
is displayed primarily on the surface of cancer cells, while only in the nucleus of healthy
cells. AS1411 binds to nucleolin on the surface, which allows for internalization of the
nucleolin-AS1411 complex. The AS1411 then causes further disruption to nucleolin
dependent pathways linked to normal cancer progression. In vitro studies have shown
AS1411 effective in treating a variety of cancer types across different cell lines. Initial
6

clinical trials have been performed showing no adverse effects while proving effective in
stabilization or even complete response. Further clinical testing is underway and the study
of the mechanisms involved continue to advance.

FIGURE 2 Quadruplex conformation of G-rich oligonucleotide allowing for aptameric
interaction with cell proteins (Bates 2009)

Another functional DNA molecule that has been studied extensively is the stem
loop, or hairpin. By controlling the sequence of nucleotides on a single DNA strand selfcomplementary segments can be arranged. When allowed to fold these segments bind to
each other through traditional Watson-Crick base pairing, creating a double stranded
structure from a single DNA strand as seen in FIGURE 3. Using this type of automatic
folding can yield complex structures with multiple loops as well as simple short sequences
with a single loop. Hairpins have been applied as molecular beacons, suppressors of
polymerase chain reactions, high-sensitivity probes, and drug carriers (Walter 1998,
Broude 2002). Chemotherapeutic agents that intercalate between the base pairs of double7

stranded DNA can be loaded into the stem region of the hairpin. Extreme changes in the
environment such as temperature, pH, or salt concentration causes destabilization of the
base pairing and denaturing of the hairpin structure. Using this effect the hairpin can be
used as a selective release vehicle of active drugs.

FIGURE 3 Hairpin, or stem loop, structure. Intercalation of doxorubicin into occurs in CG rich regions.

Doxorubicin is a common chemotherapy drug from a family known as
anthracyclines, and FIGURE 4 shows its chemical structure. It can be used for many types
of cancer and is often included in combination with other chemotherapeutic agents.
Delivery of doxorubicin is typically intravenous and can be aided by pegylation and/or
encapsulation in liposomes (Tacar 2013). Systemic exposure to doxorubicin can cause fatal
toxicity to the heart as well as significant toxicity to the brain, liver and kidneys (Chatterjee
2010). Due to these side effects the dosage of doxorubicin must be limited and other
additional therapies must be employed. A more selective release of doxorubicin would
reduce these side effects while still allowing for cancer cell destruction. The method of
action of doxorubicin is generally through intercalation with DNA and DNA-associated
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enzymes (Tacar 2013). This causes the halting of replication and transcription, effectively
halting cell proliferation, while also producing free radicals that cause further damage to
DNA and protein production. A secondary effect of these disturbances is the reduction in
cellular energy production and initiation of autophagy. Multiple other chemical pathways,
such as AMP-activated protein kinase and Bcl-2/Bax, are inhibited or activated by
doxorubicin and are known to control programmed cell death, or apoptosis (Tacar 2013).

.
FIGURE 4 Chemical structure of Doxorubicin (Agudelo 2014)

The double helix structure of DNA, with major and minor grooves and stacked base
pairs, allows for the binding of many different molecules. In the case of doxorubicin the
binding occurs due to the ability of the aromatic rings to generate a pi-stacking arrangement
between consecutive bases while the amine group remains within the minor groove.
Optimal binding has been found to occur in regions rich in cytosine-guanosine base pairs
as shown in FIGURE 3, specifically with repetition of the sequence CGATCG (Frederick,
9

1990). Using a DNA hairpin in this manner acts as a biocompatible carrier for doxorubicin
with the ability to denature with increases in temperature, thereby releasing the drug.
C. Objective
The objective of this work is to produce a versatile and selective vehicle for the
delivery and release of chemotherapeutic agents to the site of cancer cells. The overall
process is depicted in FIGURE 5. Utilizing the previously mentioned Diasynth method to
obtain gold nanoplates, a drug delivery vehicle is created through the use of single stranded
DNA molecules and an intercalating drug, doxorubicin. Release of doxorubicin is induced
via nIR laser application to heat gold nanoplates and denature the hairpin DNA. The
synthesis and processing of this vehicle is detailed as well as testing to quantify the
doxorubicin loading capacity, the bulk solution temperature during laser application, and
the release of doxorubicin as a function of successive of laser exposure.

10

FIGURE 5 A. Conjugation of DNA oligonucleotides to gold nanoplate surface. B.
Loading of doxorubicin into the DNA hairpin. C. Laser induced release of doxorubicin.
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II. MATERIALS AND METHODS
A. Instrumentation
All absorbance spectra were measured on a Varian (Palo Alto, CA) Cary 50 Bio
UV-Vis Spectrophotometer using 12 mm quartz cuvettes and at a 10x dilution in Nanopure
water, unless otherwise stated. Zeta potential and particle sizes (Dynamic Light Scattering,
DLS) were measured using a Malvern Instruments (Worcestershire, United Kingdom)
Zetasizer Nano ZS90, at a 10x dilution unless otherwise stated. Fluorescence was measured
with a Turner Biosystems (Promega, Madison, WI) Modulus Fluorometer using the green
fluorescence module accessory and glass microcell cuvettes with all readings being
undiluted unless noted. The laser used for heating of the particles was a Coherent Inc (Santa
Clara, CA) FAP System Model with a fixed emission wavelength of 817 nm and variable
power setting. Actual laser power was measured before lasering using a Coherent FieldMax
II-TO. The temperature of the solution while lasering was measured using an Omega
Engineering (Stamford, CT) Thermocouple Data Logger (OM-EL-USB-TC-USB) and
Omegasoft Data Logger Software (Rev. 6.8) using the provided type K thermocouple.
B. Reactants
The gold salt used was hydrogen tetrachloroaurate-III trihydrate (HAuCl3*3H2O)
purchased from Alfa Aesar (Ward Hill, MA 01835). A 1.76 mM solution was prepared by
dissolving 1 gram in 14.725 L of DI water in a volumetric flask protected from light with
aluminum foil. Sodium thiosulfate pentahydrate (Na2S2O3*5H2O) was purchased from
Sigma-Aldrich (St. Louis, MO) and 186.1 mg was used to create a 250 mL solution at 3
mM. Oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA)
and dissolved in Nanopure water to create stock solutions between 10 and 1 uM. See
12

TABLE 1 for oligonucleotide specifications. Dithiothreitol (C4H10O2S2) at 1 M
concentration in H2O and dry powder doxorubicin hydrochloride (C27H29NO11*HCl) were
purchased from Sigma-Aldrich (St. Louis, MI 63103).

TABLE 1: OLIGONUCLEOTIDE SPECIFICATIONS
DNA

Modifiers

Conformation

Melting
Temperature (oC)

Hairpin

3’ Thiol

Hairpin/Stem
Loop

69.7

Extinction
Coefficient at
260 nm
(L/(mol-cm))
453,600

Sequence: 5’-AGC TAG CGC TAG CGC TAG CTT TTG CTA CGC CTA GCG CTA
GCT TTT TTT TTT /3ThiolMC3-D/ -3’
AS1411

5’ Thiol

Quadruplex

67.0

298,000

Sequence: 5’- /5ThiolMC6-D/TTT TTT GGT GGT GGT GGT TGT GGT GGT GGT
GG -3’

C. Gold Nanoparticle Synthesis
GNPs were synthesized using the Diasynth process (Patel 2012) and reaction
parameters were chosen to yield particles with maximum absorbance at approximately 820
nm (James 2013) to match the wavelength at which the laser emits. Both temperature and
surface area to volume ratio of the membrane can be varied to tune the maximum
wavelength absorbance. The dialysis tubing cellulose membrane used was 43 mm wide
13

and had a 12 kDa molecular weight cutoff, purchased from Sigma-Aldrich and stored in
DI water in a refrigerator at 4oC. Before use each membrane is cut to size and rinsed
thoroughly with DI water. A membrane of 12 cm is taken and clipped on one end with a
plastic dialysis clip. Then 32.6 mL of 1.76 mM gold salt solution is added followed by
quickly adding 7.4 mL of 3 mM sodium thiosulfate solution and agitating for 5 seconds.
The membrane is then clipped on the other end while minimizing air bubbles within the
membrane, giving a final effective membrane length of 10 cm. The closed membrane is
then submerged in a bath of DI water of at least 25 L circulated and maintained at 27oC by
a Thermo (Waltham, MA) NESLAB RTE-221 Circulator. After reacting for 1 hour the
membrane is removed and the solution is emptied into a 40 mL plastic tube. The UV-Vis
spectrum of the product is analyzed to verify the peak absorbance wavelength, and size
(DLS) and zeta potential are also measured.

D. Oligonucleotide Preparation
Lyophilized oligonucleotides were used to create stock solutions in Nanopure
water. Using the provided molecular weights as provided by the supplier, 10425.9 g/mol
and 15839.4 g/mol for AS1411 and Hairpin respectively, 7.7 uM and 5 uM solutions were
created respectively. Each oligonucleotide solution is stored in 4 oC with the thiol
modification containing a disulfide bond. To become activated the disulfide bond must be
broken to form a sulfhydryl that will readily react with the gold surface. For this
dithiothreitol, DTT, is used to cleave the disulfide bond, requiring each DNA solution react
in 0.1 M DTT concentration for at least 1 hour. Immediately prior to deprotection the DNA
is exposed to a sodium phosphate buffer (PB) environment, at 0.18 M (pH 8), and heated
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to 90oC, well above the melting temperature of the DNA strands, and then allowed to cool.
A salt concentration, provided by the buffer, is needed to provide the proper base pairing
of DNA. Annealing in this way denatures the DNA and then allows it to fold in the presence
of the buffer ensuring folding before bonding to the gold. To obtain the purified, activated
oligonucleotides the excess DTT must be separated using a chromatography column. Using
GE (Buckinghamshire, United Kingdom) illustra NAP-25 columns and 10 mM PB (pH 8)
as the mobile phase the two oligonucleotides are eluted. Each sample of oligonucleotide is
then analyzed with UV-Vis spectroscopy to determine the absorbance at 260 nm which
correlates to the concentration of DNA by using the manufacturer-supplied molar
absorptivity for each strand of DNA.
E. Functionalization of Gold Nanoplates with DNA
Once the oligonucleotides are separated from the DTT via the chromatography
columns, addition of gold particles must take place within a short period of time. Once the
DTT is removed the activated sulfhydryl groups on the oligonucleotides can reform
disulfide bonds with each other. If the solution is allowed excess time in this state they
would not be able to bond to the surface of the gold and effectively give no coating of the
gold particles. Therefore, at this stage only thirty minutes is given between isolation of the
oligonucleotides and mixture of the gold nanoparticle solution with DNA. For every batch
of DNA-coated particles the following samples are created: GNPs with hairpin, GNPs with
AS1411, and GNPs with both hairpin and AS1411. The sample with both hairpin and
AS1411 molecules used an equal ratio of each oligonucleotide and each was added
simultaneously to the gold solution. The calculations used to determine the volumes of
each reactant to add to create said particles used the Beer-Lambert Law and the definition
15

of molarity. Given the absorbance, extinction coefficient, and volumes of each reactant the
number of molecules available can be determined. The extinction coefficients of the
oligonucleotides is provided by the supplier and although the precise parameter for the
GNPs has not been determined. Studies have shown spherical nanoparticles of silver and
gold to have similar extinction coefficients on the order of 109 to 1010 L/mol-cm (Navarro
2013). Due to the significantly lower volume of similarly sized plates the lower end of this
estimation was used. Variation in this parameter ultimately only becomes a factor when
looking at exact loading efficiencies, as any ratio of nanoplates to oligonucleotides will get
some degree of coating. The limiting reactant can be determined and then used to calculate
the volumes to add to create the three samples as mentioned. For this study a ratio of 1120
oligonucleotides per gold nanoparticle was used to ensure sufficient loading of DNA. It
has been shown in previous studies, and is suggested here, that uncoated gold nanoplates
are sensitive to aggregation from exposure to salt (Guo 2010). The oligonucleotide
solutions are at a 10 mM PB concentration when added to the gold solution and is then
diluted to 5 mM with the addition of Nanopure water. Additionally, irreversible
aggregation of GNPs onto the walls of containers was also mitigated by the use of low
DNA-binding tubes, such as Lobind Eppendorf (Hamburg, Germany) centrifuge tubes. All
further processes were done with all samples in parallel unless otherwise noted.
After combining the appropriate volumes of gold and oligonucleotides the samples
are incubated at 4 oC and vortexed every thirty minutes for the first three to four hours and
then further incubated at 4 oC overnight. On the next day the excess DNA is removed
through serial centrifugations and washings. Centrifugation was performed using a
Beckman Coulter (Brea, CA) Microfuge 16 set at 2500 xg for 4 minutes. The resulting
16

colorless supernatant was collected and the pellet was resuspended in 5mM PB solution.
The sample was then sonicated with a Misonix (Farmingdale, NY) Microson XL 2000
sonication probe 10 times in 1 second bursts and vortexed to fully resuspend any particles.
This centrifuging, supernatant removal, and resuspension is performed three times for each
sample. After this stage each sample and corresponding supernatant is analyzed by UVVis spectroscopy, DLS, and zeta potential measurement.
F. Loading Doxorubicin Into Hairpin
A 100 uM solution of doxorubicin hydrochloride was created from dry power by
dissolving 0.3 mg into 5 mL of Nanopure water and a fraction of this stock was taken and
diluted to 10 uM for addition to GNP-DNA particles. Previous studies of doxorubicin
loading at a concentration of 5 uM for 300 nM DNA hairpin showed saturation of the
hairpin at 4 doxorubicin molecules per hairpin (Luo 2011). Due to the decreased stability
of the gold nanoplates in high salt concentrations, to which doxorubicin hydrochloride
contributes, the concentration of doxorubicin used to load the particles was limited to 0.5
uM. This will not provide saturation of the hairpin but will still allow for some loading of
dox and provide a measurable fluorescence upon release. Maximizing dox loading is not
crucial for proof of concept and preventing aggregation of the particles is crucial to further
testing. To load the particles with doxorubicin a GNP-DNA sample is diluted to an
absorbance, or optical density (OD), of 3 with a doxorubicin concentration of 0.5 uM using
5 mM PB as needed for dilution. For this step only GNPs with hairpin and GNPs with
hairpin and AS1411 were used as GNPs with AS1411 have no ability to intercalate with
dox, as it does not have repeating C-G bases or traditional base pairing to provide the pi
stacking arrangements. These samples were allowed 2 hours to react at room temperature,
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approximately 26°C. To remove excess dox the samples were centrifuged and washed in a
manner analogous to the DNA loading protocols. Centrifugation was performed at 1000
xg for 2 minutes or 4 minutes if no aggregation was seen. The largely colorless supernatant
was collected leaving a purple pellet that is then resuspended with 5 mM PB and vortexed.
This process is performed up to 3 times if no aggregation occurs but was done twice in
some cases to prevent significant loss of particles due to irreversible aggregation.
Aggregation in previous samples was marked by loss of SPR bands, size analysis showing
several fold increase, and zeta potential readings approaching zero. Visibly these changes
were coincident with rapid change in color, from purple to blue or gray, and the collection
of gray film or particulates on tube walls. Supernatants are analyzed for fluorescence to
determine the amount of dox present, which can be used to estimate the number of hairpin
particles present on the GNPs. The resulting particles are now GNPs functionalized with
hairpin or hairpin/AS1411 oligonucleotides intercalated with doxorubicin. These samples
are then analyzed for UV-Vis spectra for particle content and absorbance at 817 nm.
E. Laser-induced Release of Doxorubicin
Using the nIR absorbance peak obtained from the UV-Vis spectrum the samples are diluted
to 0.5 OD and a volume of 0.5 mL using Nanopure water. Before laser application each
sample is then analyzed for fluorescence along with a control, which has not been loaded
with dox, similarly diluted from the same batch of functionalized particles. A fluorescence
measurement was taken 3 times for each sample. In turn each sample was dispensed into a
48 well plate and heated with a laser. The 817 nm wavelength laser was set to 8200 mA
(1000 mW) and emitted 21 cm above the target. The laser area consisted of a circle with a
diameter of 1.25 cm covering the well fully. The actual laser power at the well plate was
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measured with a Coherent Laser Power Meter as approximately 800 mW. Duration of laser
application was 5 minutes followed by immediate collection and centrifugation at 1000 xg
for 2 to 4 minutes, matching the washing setting used to wash the sample in the dox loading
process. The supernatant was collected and the pellet resuspended to 0.5 mL with Nanopure
water and vortexed briefly. This process is performed 3 times to obtain a release profile of
doxorubicin. Temperature is also measured during laser application using an Omega
thermocouple probe and USB data logging device. After the final centrifugation and
supernatant collection the 3 collected supernatants are centrifuged at 1000 xg for 4 minutes
to pellet any coincident gold in solution. Then 200 uL from the top of each supernatant is
analyzed for fluorescence, taking 3 measurements per sample. This procedure is done for
3 replicates of dox loaded and control samples of GNPs with hairpin and GNPs with hairpin
and AS1411.
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III. RESULTS AND DISCUSSION
A. Gold Nanoparticle Synthesis
GNPs were produced using the Diasynth method and expected to contain a large
fraction of plates, comparatively few spheres, and with a controllable SPR band within the
NIR range. The spectrum of a sample used for subsequent functionalization, dox loading,
and lasering are presented in FIGURE 6.The UV-Vis absorbance spectra show favorable
SPR bands that will absorb highly within the therapeutic window and at the 817 nm
wavelength of the available laser. The ratio of NIR band to 530 nm band can also
approximate the ratio of plates to spheres. As nanospheres only exhibit SPR bands in the
visible region and nanoplates exhibit in the nIR region these two can be easily
differentiated within a spectra measurement. Typically the nIR peak should be 2 times as
large as a 530 nm peak for a composition consisting of mainly plates (Patel 2012). The size
for the nanoplates, identified as contributing to the majority of intensity readings from
DLS, was found to be 68.46 nm on average, with a standard deviation of 2.74 nm. The
measured zeta potentials averaged -31.48 mV with a standard deviation of 0.95 mV.
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FIGURE 6 UV-Vis spectrum of representative gold nanoparticles synthesized using the
Diasynth method. The two peaks approximate the ratio of spheres and plates. Absorbance
in therapeutic windows indicates suitability for laser absorption.

Synthesis of GNPs using the Diasynth methods as described previously produced
particle with SPR bands controllable through variation in temperature and dialysis
membrane length. Other variations in the reactants such as supplier and duration in solution
seem to cause changes in this response giving a variation in absolute characteristics but
maintaining relatively predictable synthesis outcomes. Through iterative refinement of the
optimal temperature and membrane length the SPR peak was tuned to obtain the particles
detailed above. For the purposes of this research the spherical particles act as a
contaminant, and theoretically should be functionalized in subsequent steps, while the
practical focus is on the nanoplates. With further research into the characteristics,
interactions, and application of gold nanoplates the isolation and processing of these
particle can be further refined, but is outside of the scope of this project. The use of a fixed
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wavelength laser at the wavelength of max absorption for the plates is assumed to
effectively only significantly heat the nanoplate population.

B. Functionalization of GNPs with DNA
The success of coating the GNPs with DNA was to be confirmed through change
in the size and zeta potential of the particles. As shown in TABLE 2 the size increases
across all samples after reacting with the oligonucleotides. The average size increase is
23.5, 42.23, and 26.13 nm for GNP-Hairpin, GNP-AS1411, and GNP-Hairpin-AS1411
respectively, with GNP-AS1411 having the highest standard deviation at 23.9 nm. Zeta
potential had more consistent data across samples with the average change in potential of
-11.90, -11.40, and -9.52 mV respectively, with the highest standard deviation being 2.47
mV. Analysis of the variance (Appendix Ia.) showed that there was a significant difference
in size between bare and coated particles at a 95% confidence level, while coating mixture
was not a significant factor. Similarly, it shows a significant difference at a 95% confidence
level in zeta potential for bare and coated particles but found the type of coating not a
significant factor.
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TABLE 2 SIZE AND ZETA POTENTIAL OF DNA-FUNCTIONALIZED GNPS

Particle Size (nm)
DNABare
Change
coated

Zeta Potential (mV)
DNABare
Change
coated

GNP-Hairpin-1

70.40

95.66

25.26

-30.8

-44.15

-13.35

GNP-Hairpin-2

70.40

100.55

30.15

-30.80

-44.10

-13.30

GNP-Hairpin-3

66.52

81.62

15.1

-32.15

-41.20

-9.05

GNP-Hairpin Average
(Standard Deviation)

69.11
(2.23)

92.61
(9.83)

23.50
(7.68)

-31.25
(0.78)

-43.15
(1.69)

-11.90
(2.47)

GNP-AS1411-1

70.40

85.63

15.23

-30.80

-40.25

-9.45

GNP-AS1411-2

66.52

127.3

60.78

-32.15

--46.40

-14.25

GNP-AS1411-3

66.52

117.2

50.68

-32.15

-42.65

-10.5

GNP-AS1411 Average
(Standard Deviation)

67.81
(2.24)

110.04
(21.74)

42.23
(23.92)

-31.70
(0.78)

-43.10
(3.10)

-11.40
(2.52)

GNP-Hairpin-AS1411-1

70.40

94.7

24.3

-30.8

-40.70

-9.90

GNP-Hairpin-AS1411-2

66.52

99.22

32.70

-32.15

-41.95

-9.80

GNP-Hairpin-AS1411-3

66.52

87.92

21.40

-32.15

-41.00

-8.85

GNP-Hairpin-AS1411
Average
(Standard Deviation)

67.81
(2.24)

93.95
(5.69)

26.13
(5.87)

-31.70
(0.78)

-41.22
(0.65)

-9.52
(0.58)

The overall trend that points to successful binding is the significant but small
increase in size. This is as one would expect as the physical size of the complex is
increasing with the addition of oligonucleotides onto all sides of the particle. Assuming a
length of 0.33 nm per base (Mandelkern, 1981) the single stranded hairpin and AS1411
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would be 16.83 nm and 10.56 nm respectively. After folding into their respective structures
of double strand and quadruplex they would then be approximately 8.42 nm and 2.64 nm.
Binding of these structures onto each side of the nanoparticle would then increase the
overall size by at least 16 nm and 5 nm respectively. The possibility of crosslinking
multiple oligonucleotides through base pairing or other interactions is an area of further
research, but could create larger size increases. Additionally, the DLS reading perceives
the hydration sphere of the particle taking into effect the interaction with water, thus
increasing the apparent size of charged particles. Alternatively, any irreversible
aggregation would be expected to increase the size much more dramatically and bring the
zeta potential toward zero.
The UV-Vis spectra as seen in FIGURE 7 shows a set of coated particles that
maintain a high SPR peak in the nIR range. This is crucial to the success of the particles as
a large shift away from the laser frequency or a loss in absorbance would reduce the
efficacy of these particles to heat with 817 nm laser application. The spectra changes
associated with coating of the particles seems to vary little between coating composition
and depends more on the source bare GNPs . This could include affinity for aggregation
and presence of spherical particles. As mentioned previously the resulting particles do have
some variation despite controllability in the placement of the nIR peak.
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FIGURE 7 UV-Vis spectra of DNA-coated GNPs. The peaks shift slightly but maintain
within the therapeutic window and absorbance at 817 is still suitable for laser absorption.

The procedure for functionalizing GNPs with oligonucleotides was taken from one
study using similar approaches working with gold nanospheres (Luo 2011). The main
difference between this study and those previously is that gold nanospheres have shown
much more stability to the addition of salt where gold nanoplates tend to aggregate (Fan
2010). This is likely due to the geometry providing less uniform repulsion allowing for
closer approach of plates along the planar faces leading to stacking. It has also been shown
that the loading of DNA onto GNPs can be achieved through slow incremental increase in
the salt concentration as high as 0.7 M NaCl for absolute maximum packing (Hurst 2006).
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However a portion of DNA will still bond to the particle surface without significant
addition of salt. The occurrence of aggregation from salt addition or other incidental
processes caused a visible change in the solution from a dark purple to blue or gray with
eventual colorlessness and gray or black large particulates settling and adhering to the tube
surface. This reaction can also be surmised from DLS measurements, showing a size
change from less than 100 nm to several hundreds of nanometers as shown in TABLE 3,
and UV-Vis spectra, shifting from a strong peak to a low broad absorbance with no
discernable peak as seen in FIGURE 8. Due to the sensitivity of the nanoplates to high salt
concentration, further processing was done with no additional salt added beyond the
maintenance of a 5 mM PB concentration. Possible methods of stabilization include
capping agents, such as citrate, or coatings of long hydrophilic chains, such as polyethylene
glycol. Such changes must be taken into consideration for the overall effect on the further
processing and performance of the particles as these changes could have effects on the
consistency, yield of production, and release of dox.
TABLE 3
SIZE AND ZETA POTENTIAL OF AGGREGATED DNA-FUNCTIONALIZED GNPS
Particle Size (nm)
Bare DNA-coated
GNP-Hairpin

86.16

407.65

GNP-AS1411

86.16

354.75

GNP-Hairpin-AS1411 86.16
GNP-DNA Average
86.16
(Standard Deviation)
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FIGURE 8 UV-Vis spectra of aggregated DNA functionalized GNPs. No substantial NIR
peak is visible indicating the high absorbance plates are no longer present.

Despite attempts at quantification the amount of DNA loaded onto the GNPs could
not be directly quantified at this time with the available reactants and analysis tools.
Theoretically the 260 nm absorbance of supernatants from the washing of GNP-DNA
particles would contain only absorbance from unbound DNA. However, this proved to be
unrealistic as absorbance appeared higher than that of the DNA. This impossibly high
reading indicated some other 260 nm absorbing particles, pointing to spherical gold
remaining in the supernatant. Similarly, attempting to strip bound DNA from coated
particles showed the same problem. DTT was used to break the thiol bond and release the
DNA followed by centrifugation to pellet the GNPs while leaving the DNA in the
supernatant. Again a second contributing factor appeared to be absorbing at 260 nm in
addition to the DNA. However, because the previous study achieved saturation of this same
hairpin, at 4 dox molecules per oligonucleotide, the number of hairpins can be estimated
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from the quantification of dox loading. This is easily determined through fluorescence and
is covered more extensively in subsequent sections.

B. Loading Doxorubicin into Hairpin
After confirmation of DNA binding to the GNPs the hairpin molecules were loaded
with dox for later release. As mentioned previously, attempts to use the concentration of
dox found in other established protocols (Luo 2011) lead to aggregation of the particles
due to high salt concentration. Therefore a reduced concentration of dox was used for
loading. The analysis of the particles after loading and washing saw some decreases in
overall quality of the nIR peak but not as severe as seen with aggregation. Additionally,
during processing the visible color of the particles remained constant and minimal
adherence to the tube walls was seen. FIGURE 9 shows a spectrum of a sample at this
stage. Size and zeta measurements could not be reasonably taken at this stage due to
volumetric constraints.
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FIGURE 9 UV-Vis spectra of GNP-Hairpin-AS1411 loaded with dox. Aggregation
effects disproportionately affect the plates causing a decrease in plate to sphere
absorbance ratio

Dox loading was quantified indirectly by measuring the fluorescence of the wash
supernatants. Using the raw fluorescence measurements and a fluorescence calibration
curve (see Appendix 1D) for dox the concentration of dox in the supernatants can be
determined. With an initial concentration of 0.5 uM dox added during loading the dox
concentration in the supernatant is assumed to be the difference between initial
concentration and the loaded concentration. From this relationship the amount of
successfully loaded dox can be calculated followed by total molecules of dox given the
volume of supernatant. Then the known absorbance of loaded particles at 820 nm can be
used again with the Beer-Lambert equation to determine the total number of nanoplates
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present in the volume of loaded particles. The number of dox molecule and gold nanoplates
in the final sample have been found and can be used to find the number of dox per
nanoplate. Conservatively assuming 1 molecule of dox per hairpin molecule, as Luo et al.
found previously a saturation of 4, the number of hairpins per gold nanoparticle can be
calculated. The number of oligonucleotides per plate estimated from dox loading is detailed
in TABLE 4.
TABLE 4
NUMBER OF HAIRPIN OLIGONUCLEOTIDES PER GOLD NANOPLATE
Sample
GNP-Hairpin GNP-Hairpin-AS1411
Replicate 1
369.6
370.5
Replicate 2
383.5
385.5
Replicate 3
385.4
386.3
Average Oligonucleotides per nanoplate
379.5
380.8
(Standard Deviation)
(8.6)
(8.9)

These results indicate a reasonable number of oligonucleotides, considering the
indirect nature of the calculations. Because the hairpin-AS1411 sample is reacted with half
the quantity of hairpin as the hairpin-only sample one would expect a noticeable decrease
in dox loading capabilities but this is not seen. The difference between samples is relatively
small potentially meaning that hairpin binding is preferential to AS1411 binding.
Regardless of this difference there is evidence that there is loading of dox onto the hairpins
which is crucial to the later release study.
This indirect type of quantification is not ideal but can serve at least as a check for
sufficient dox washing. Seeing values indicative of high dox concentrations in supernatants
would mean that free dox could still be in high concentration around the loaded particles.
Assumptions inherent in this method of determining DNA loading include the previously
30

mentioned extinction coefficient of gold nanoplates, relatively little interference of
fluorescence by any gold nanospheres, and sufficient washing in previous steps. The
theoretical physical limit of DNA loading can be approximated using surface area for a
plate with edge length of 70 nm, thickness of 2 nm, and the diameter of a double helix of
2 nm (Mandelkern, 1981). This could give a plate total surface area of 7000 nm2, and at
90% efficient hexagonal packing a maximum of 500 oligonulceotides per gold nanoplate.
To better quantify the DNA loading other studies have used fluorescently labeled
oligonucleotides and a similar approach could be used for further study of the loading
characteristics of these particles.
C. Laser-induced Release of Doxorubicin
After loading the particles with dox the samples were exposed to laser light, at 817
nm wavelength, a power of 800 mW, and duration of 5 minutes. The particles were then
removed via centrifugation, and the amount of free dox in the supernatants quantified
through fluorescence measurements. The samples showed a consistent release pattern
despite some variations likely due to the salt sensitivity of the complexes. The average
fluorescence reading after each lasering can be seen in FIGURE 10 for GNP-Hairpin and
FIGURE 11 for GNP-Hairpin-AS1411. Also shown are the fluorescence readings from
control GNP-DNA particles without dox that were lasered and processes in the same way.
The percentage that each laser application contributed to the total release is also
represented. The average fluorescence reading for the GNP-Hairpin particles is 336.6,
227.4, and 167.6 FSU for the first, second, and third laser applications respectively.
Meanwhile the control registered 140.1, 140.3, and 136.2 FSU for the same points. The
GNP-Hairpin-AS1411 particles were a bit lower at 197.1, 155.4, and 142.9 FSU, with its
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control at 139.9, 129.2, and 128.1 FSU. The analysis of the variance of these results showed
that significant factors at 95% confidence include laser number, loaded or non-loaded, and
GNP-Hairpin or GNP-Hairpin-AS1411. This indicates that these all indeed effect the
amount of dox released.

FIGURE 10 Fluorescence readings of supernatants from lasered GNP-Hairpin samples
loaded with dox. The first laser releases the most dox and subsequent lasering approaches
the control. Laser light exposure was 817 nm wavelength at 800mW for 5 minutes.
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FIGURE 11 Fluorescence readings of supernatants from lasered GNP-Hairpin-AS1411
samples loaded with dox. The first laser releases the most dox and subsequent lasering
approaches the control. Laser light exposure was 817 nm wavelength at 800mW for 5
minutes

These results indicate that there was a release of dox due to the laser application
and that the first laser application releases most of the dox. Analysis of the variance
(Appendix I B) showed a significant difference between the dox loaded and control
samples, and also indicated that the effects of laser number and coating type were
significant to fluorescence measurement. This effectively serves as proof of concept that
the particles do behave as proposed to serve as a possible vehicle for delivery and release
of doxorubicin. One possible factor biasing these results could include the methodology of
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collecting the free dox after each lasering. The above results could be a symptom of dilution
due to centrifugation and resuspension in the process thus showing fluorescence
approaching the control. This is possible but should be mitigated by sufficient washing of
excess dox during the loading phase. This specific possibility could be further studied by
modifying the washing process, to more thoroughly ensure excess dox removal, and then
release the dox with lasering to compare the results.

The other measurement taken during lasering was bulk solution temperature, seen
in TABLE 5. All samples saw heating exceeding that of water with a maximum
temperature of 58oC and minimum of 37.5oC. The overall average was 46.3±7.6oC for
particles loaded with dox and 43.4±3.7oC for particles with no dox. Analysis of the variance
(Appendix I C) showed that there was no significant difference in the maximum
temperature reached for any factor differentiating samples, including DNA coating, dox
loading, or laser number.
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TABLE 5 Maximum temperatures during laser application
Maximum Temperature (oC)
Sample
Laser 1 Laser 2 Laser 3
GNP-Hairpin-Dox 1
54
54.5
51
GNP-Hairpin-Dox 2
43.5
37.5
34
GNP-Hairpin-Dox 3
54.5
48
45
GNP-Hairpin-1
45
41
37.5
GNP-Hairpin-2
52
48
45.5
GNP-Hairpin-3
45
40.5
38
GNP-Hairpin-AS1411-Dox 1
40.5
40
38
GNP-Hairpin-AS1411-Dox 2
43
40.5
40.5
GNP-Hairpin-AS1411-Dox 3
58
57
53.5
GNP-Hairpin-AS1411-1
45
44
40.5
GNP-Hairpin-AS1411-2
47
43
39.5
GNP-Hairpin-AS1411-3
45
44
40.5
Water
27
26
26

These findings confirm that all samples were heated nearly the same while the
variation could not be attributed to one particular factor. This likely means that any
variation comes from processes in the production of the coated GNPs or even the
production of the bare particles. Ultimately it is most important that the gold particles be
heated enough to denature the hairpin structure to allow dox to be released. However the
bulk temperature read here is not seen to be above 60oC, well below the melting
temperature (TM) of the hairpin at 69.7oC. The important realization here is that the local
heating at the particle surface induced by the SPR effect is effectively dampened by the
large volume of water into which the heat has to dissipate, and therefore oligonucleotides
conjugated to the particle surface likely experience greater thermal fluctuations compared
to the bulk solutions. One study found the bulk temperature induced by this effect to be as
high as 100 oC (Gobin 2010). This is also confirmed by the fact that despite bulk temperate
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of the solution being lower than the TM for the hairpin, significant dox release is still seen,
which means that hairpin must be denaturing. The ability to effectively achieve hairpin
denaturation and dox release at bulk temperatures near 43oC is very useful in a practical
sense for achieving hyperthermic ablation of cancer cells without causing significant heatrelated damage to surrounding tissue (Kobayashi 2011). This data is also useful for future
studies in correlating bulk temperature to the amount of dox released over time, with
temperature being an easily measurable metric.
IV. FUTURE WORK
The results presented here serve as a first look at the possibility of using gold
nanoplates as a delivery system for multiple chemotherapeutic agents. Although the data
presented here shows promise there is much left work to be done before any significant
need can be met. Overall the data presented would benefit from more samples and
refinement of the individual processes to further analyze the therapeutic potential of these
particles. Other studies on the underlying processes of the related work, such as
oligonucleotide packing on gold nanoplates or preferential binding of different
oligonucleotides would also be greatly beneficial. Probably the most commonly found
problem in this study was the aggregation of the gold nanoplates. This process has been
studied with other GNPs but because not much has been done with pure nanoplates there
is not much guidance for preventing aggregation. The methods and data presented here
only represent a small subset of the potential ways of coating these particle, so it is very
likely another method could cause less aggregation. A method of resisting aggregation in
the presence of salt would allow for a much more controllable loading of oligonucleotides
as mentioned previously. This would allow for a controllable maximum dox load to
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simplify future studies looking at oligonucleotide loading, dox loading, or even needed
therapeutic concentrations of particles. Precisely determining the extinction coefficient of
gold nanoplates would allow for a more accurate calculation for the number of gold
nanoplates in a given solution.
The isolation of gold nanoplates or the synthesis of pure gold nanoplates is another
thing that is currently being researched. As mentioned other techniques to analyze the
loading of both DNA and dox would shed light on some of the possible hurdles encountered
in this project. Ultimately, assuming continued interest and feasibility in this type of
delivery vehicle, the next step after process optimization is live studies studying the
efficacy of particles against cancer. This would include in vitro studies of cancerous and
healthy cells, examining both cytotoxicity upon release to cancer and biocompatibility with
healthy cells. Beyond that realm would be clinical studies in animals, and eventually
humans, before being a new tool in the treatment of cancer. Even if that is not the final end
point of this specific research it is sure to help the overall research into the possibilities of
GNPs and nanoparticle drug delivery vehicles.
V. CONCLUSION
The work presented here has attempted to prove the potential of gold nanoplates
coated with DNA oligonucleotides as a delivery vehicle for the controlled delivery of
cancer drugs. GNPs with an SPR band in the nIR range were synthesized using the
Diasynth method to preferentially separate nanoplates from nanospheres. The particles
were then coated with two different DNA oligonucleotides with corresponding increases
in particle size and more negative zeta potential. Doxorubicin was then intercalated into
the attached DNA which was confirmed via fluorescence measurements. Laser induced
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release of doxorubicin from DNA was shown in bench top tests through fluorescence
measurements.
Stability of gold nanoplates continues to be area in need of research as the optimal
processing of these particles become ever more valuable. The processes presented here
produced the proof of concept for these particles, but much room remains for optimization
or modification. Further research into each aspect of the principles driving these reactions
is needed to better quantify and understand these processes. Modification to enhance the
abilities of these particles can also be explored as much work has already been done with
gold nanospheres as drug delivery vehicles.
After refining the synthesis process in vitro cell studies are the next step for testing
the therapeutic potential of these particles. The promise of a selectively released
chemotherapy drug with multiple molecules to treat cancer is a great improvement over
traditional chemotherapy, greatly reducing the side effects while potentially increasing the
efficacy. The ultimate potential of this research is ultimately the full production and use of
these or similar particles for cancer therapy in patients.
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APPENDIX
A. DNA Loading Statistical Analysis
General Factorial Regression: Size versus Blocks, Oligos, Stage
Factor Information
Factor
Oligos
Stage

Levels
3
2

Values
Hairpin, AS1411, 1to1
Bare, DNA

Analysis of Variance
Source
Model
Blocks
Linear
Oligos
Stage
Error
Total

DF
5
2
3
2
1
12
17

Adj SS
4692.4
212.9
4479.5
259.8
4219.7
1328.4
6020.9

Adj MS
938.5
106.4
1493.2
129.9
4219.7
110.7

F-Value
8.48
0.96
13.49
1.17
38.12

P-Value
0.001
0.410
0.000
0.342
0.000

FIGURE 12 Residual plots for the size analysis of DNA loading
General Factorial Regression: Zeta versus Blocks, Oligos, Stage
Factor Information

39

Factor
Oligos
Stage

Levels
3
2

Values
Hairpin, AS1411, 1to1
Bare, DNA

Analysis of Variance
Source
Model
Blocks
Linear
Oligos
Stage
Error
Total

DF
5
2
3
2
1
12
17

Adj SS
550.004
8.584
541.420
2.954
538.467
25.572
575.576

Adj MS
110.001
4.292
180.473
1.477
538.467
2.131

F-Value
51.62
2.01
84.69
0.69
252.69

P-Value
0.000
0.176
0.000
0.519
0.000

FIGURE 13 Residual plots for the zeta analysis of DNA loading
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B. Laser Induced Dox Release Statistical Analysis
General Factorial Regression: FSU versus Dox, Hairpin or 1to1, Laser number
Factor Information
Factor
Dox
Hairpin or 1to1
Laser number

Levels
2
2
4

Values
Dox, No Dox
Hairpin, 1to1
0, 1, 2, 3

Analysis of Variance
Source
Model
Linear
Dox
Hairpin or 1to1
Laser number
2-Way Interactions
Hairpin or 1to1*Laser number
Error
Lack-of-Fit
Pure Error
Total

DF
8
5
1
1
3
3
3
39
7
32
47

Adj SS
216016
211649
84403
23223
104022
4367
4367
202022
45267
156755
418038

Adj MS
27002
42330
84403
23223
34674
1456
1456
5180
6467
4899

F-Value
5.21
8.17
16.29
4.48
6.69
0.28
0.28

P-Value
0.000
0.000
0.000
0.041
0.001
0.839
0.839

1.32

0.273

FIGURE 14 Residual plots for statistical analysis of dox release
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C. Temperature Data Analysis
Multilevel Factorial Design
Factors:
Base runs:
Base blocks:

3
12
1

Replicates:
Total runs:
Total blocks:

3
36
1

Number of levels: 2, 2, 3

General Factorial Regression: Temp versus Dox, DNA, Laser
Factor Information
Factor
Dox
DNA
Laser

Levels
2
2
3

Values
Dox, No Dox
Hairpin, Hairpin-AS1411
Laser 1, Laser 2, Laser 3

Analysis of Variance
Source
Model
Linear
Dox
DNA
Laser
Error
Lack-of-Fit
Pure Error
Total

DF
4
4
1
1
2
31
7
24
35

Adj SS
279.74
279.74
75.11
6.25
198.37
1009.76
19.93
989.83
1289.50

Adj MS
69.934
69.934
75.111
6.250
99.187
32.573
2.847
41.243

F-Value
2.15
2.15
2.31
0.19
3.05

P-Value
0.099
0.099
0.139
0.664
0.062

0.07

0.999
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FIGURE 15 Residuals for temperature analysis
D. Doxorubicin calibration curve
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FIGURE 16 Fluorescence calibration curve for Doxorubicin
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